Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Da Hyun | - |
dc.contributor.author | Han, Dai Hoon | - |
dc.contributor.author | Nam, Ki Taek | - |
dc.contributor.author | Park, Jeong Su | - |
dc.contributor.author | Kim, Soo Hyun | - |
dc.contributor.author | Lee, Milim | - |
dc.contributor.author | Kim, Gyuri | - |
dc.contributor.author | Min, Byung Soh | - |
dc.contributor.author | Cha, Bong-Soo | - |
dc.contributor.author | Lee, Yu Seol | - |
dc.contributor.author | Sung, Su Haeng | - |
dc.contributor.author | Jeong, Haengdueng | - |
dc.contributor.author | Ji, Hye Won | - |
dc.contributor.author | Lee, Moon Joo | - |
dc.contributor.author | Lee, Jae Sung | - |
dc.contributor.author | Lee, Hui-Young | - |
dc.contributor.author | Chun, Yoomi | - |
dc.contributor.author | Kim, Joungmok | - |
dc.contributor.author | Komatsu, Masaaki | - |
dc.contributor.author | Lee, Yong-ho | - |
dc.contributor.author | Bae, Soo Han | - |
dc.date.available | 2020-02-28T00:43:19Z | - |
dc.date.created | 2020-02-07 | - |
dc.date.issued | 2016-10 | - |
dc.identifier.issn | 0891-5849 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/7857 | - |
dc.description.abstract | Oxidative stress is important for the pathogenesis of nonalcoholic fatty liver disease (NAFLD), a chronic disease that ranges from hepatic steatosis to nonalcoholic steatohepatitis (NASH). The nuclear factor erythroid 2-related factor 2-Kelch-like ECH associated protein 1 (Nrf2-Keapl) pathway is essential for cytoprotection against oxidative stress. In this study, we found that oxidative stress or inflammatory biomarkers and TUNEL positive cells were markedly increased in NASH patients compared to normal or simple steatosis. In addition, we identified that the hepatic mRNA levels of Nrf2 target genes such as Nqo-1 and GSTA-1 were significantly increased in NASH patients. Ezetimibe, a drug approved by the Food and Drug Administration for the treatment of hypercholesterolemia, improves NAFLD and alleviates oxidative stress. However, the precise mechanism of its antioxidant function remains largely unknown. We now demonstrate that ezetimibe activates Nrf2-Keapl pathway which was dependent of autophagy adaptor protein p62, without causing cytotoxicity. Ezetimibe activates AMP-activated protein kinase (AMPK), which in turn phosphorylates p62 (p-S351) via their direct interaction. Correspondingly, Ezetimibe protected liver cells from saturated fatty acid-induced apoptotic cell death through p62-dependent Nrf2 activation. Furthermore, its role as an Nrf2 activator was supported by methione- and choline-deficient (MCD) diet-induced NASH mouse model, showing that ezetimibe decreased the susceptibility of the liver to oxidative injury. These data demonstrate that the molecular mechanisms underlying ezetimibe's antioxidant role in the pathogenesis of NASH. (C) 2016 Elsevier Inc. All rights reserved. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCIENCE INC | - |
dc.relation.isPartOf | FREE RADICAL BIOLOGY AND MEDICINE | - |
dc.subject | FATTY LIVER-DISEASE | - |
dc.subject | TRANSCRIPTION FACTOR NRF2 | - |
dc.subject | INSULIN-RESISTANCE | - |
dc.subject | METABOLIC SYNDROME | - |
dc.subject | HEPATIC STEATOSIS | - |
dc.subject | ANTIOXIDANT RESPONSE | - |
dc.subject | SELECTIVE AUTOPHAGY | - |
dc.subject | KEAP1-NRF2 PATHWAY | - |
dc.subject | CELL-GROWTH | - |
dc.subject | THERAPY | - |
dc.title | Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000387995400048 | - |
dc.identifier.doi | 10.1016/j.freeradbiomed.2016.09.009 | - |
dc.identifier.bibliographicCitation | FREE RADICAL BIOLOGY AND MEDICINE, v.99, pp.520 - 532 | - |
dc.identifier.scopusid | 2-s2.0-84987932364 | - |
dc.citation.endPage | 532 | - |
dc.citation.startPage | 520 | - |
dc.citation.title | FREE RADICAL BIOLOGY AND MEDICINE | - |
dc.citation.volume | 99 | - |
dc.contributor.affiliatedAuthor | Lee, Jae Sung | - |
dc.contributor.affiliatedAuthor | Lee, Hui-Young | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | NAFLD | - |
dc.subject.keywordAuthor | Ezetimibe | - |
dc.subject.keywordAuthor | Nrf2 | - |
dc.subject.keywordAuthor | P62 | - |
dc.subject.keywordAuthor | AMPK | - |
dc.subject.keywordAuthor | NASH | - |
dc.subject.keywordPlus | FATTY LIVER-DISEASE | - |
dc.subject.keywordPlus | TRANSCRIPTION FACTOR NRF2 | - |
dc.subject.keywordPlus | INSULIN-RESISTANCE | - |
dc.subject.keywordPlus | METABOLIC SYNDROME | - |
dc.subject.keywordPlus | HEPATIC STEATOSIS | - |
dc.subject.keywordPlus | ANTIOXIDANT RESPONSE | - |
dc.subject.keywordPlus | SELECTIVE AUTOPHAGY | - |
dc.subject.keywordPlus | KEAP1-NRF2 PATHWAY | - |
dc.subject.keywordPlus | CELL-GROWTH | - |
dc.subject.keywordPlus | THERAPY | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Endocrinology & Metabolism | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Endocrinology & Metabolism | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.